Security key
98420N105
Xenon Pharmaceuticals Inc. - Common Shares (XENE)
CUSIP: 98420N105
Q4 2020 13F Holders as of 31 Dec 2020
- Security type / class
- Equity / Common Shares
- Shares outstanding
- 92,799,600
- Total 13F shares
- 28,020,659
- Share change
- -361,255
- Total reported value
- $430,912,842
- Reported price per share
- $15.38
- Number of holders
- 79
- Value change
- -$1,905,185
- Number of buys
- 31
- Number of sells
- 27
Security identity
Holder snapshot
Report period
Q4 2020
Institutions
79
Top holders
10
XENE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2021
Previous quarter: Q3 2020
Xenon Pharmaceuticals Inc. SEC filings
Xenon Pharmaceuticals Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 98420N105
Recent filing periods:
Ownership snapshot
Top reported holders of XENE - Xenon Pharmaceuticals Inc. - Common Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
BVF INC/IL
13D/G signal
—
Evidence rows
15
Latest as of
30 Sep 2020
13F
Lead comparable stake: 3.8%
Showing 1-6 of 15 holder rows.
Rank 1 holder
BVF INC/IL
13F
- Ownership
- 3.8%
- Position
- $38.74M
Rank 2 holder
Avoro Capital Advisors LLC
13F
- Ownership
- 3%
- Position
- $31M
Rank 3 holder
FMR LLC
13F
- Ownership
- 2.8%
- Position
- $29.06M
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BVF INC/IL |
13F
Company
|
3.8%
|
$38,738,000
3,499,346 shares
|
— | 30 Sep 2020 |
| Avoro Capital Advisors LLC |
13F
Company
|
3%
|
$30,996,000
2,800,000 shares
|
— | 30 Sep 2020 |
| FMR LLC |
13F
Company
|
2.8%
|
$29,055,000
2,624,620 shares
|
— | 30 Sep 2020 |
| ORBIMED ADVISORS LLC |
13F
Company
|
2.7%
|
$27,652,000
2,497,917 shares
|
— | 30 Sep 2020 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
Company
|
2.6%
|
$27,122,000
2,450,000 shares
|
— | 30 Sep 2020 |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
Company
|
1.4%
|
$14,104,000
1,274,100 shares
|
— | 30 Sep 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
79
Shares
28,020,659
Rows available
79
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
Compare Q4 2020 vs Q3 2020 Across Filers
Q3 2020 holders
79
Q4 2020 holders
79
Holder diff
0
| Investor | Q3 2020 Shares | Q4 2020 Shares | Share Diff | Share Chg % | Q3 2020 value | Q4 2020 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend